The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
1236767215 12367672 15 F 2016 20160922 20160513 20160929 EXP CA-PFIZER INC-2016129526 PFIZER 84.00 YR F Y 0.00000 20160929 MD CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
1236767215 12367672 1 PS XELJANZ TOFACITINIB CITRATE 1 Oral 5 MG, 1X/DAY 270 MG 203214 5 MG TABLET QD
1236767215 12367672 2 SS XELJANZ TOFACITINIB CITRATE 1 Oral 5 MG, 2X/DAY 270 MG 203214 5 MG TABLET BID
1236767215 12367672 3 SS XELJANZ TOFACITINIB CITRATE 1 Oral 5 MG/DAY 270 MG 203214 5 MG TABLET
1236767215 12367672 4 SS XELJANZ TOFACITINIB CITRATE 1 Oral 5 MG, 2X/DAY 270 MG 203214 5 MG TABLET BID
1236767215 12367672 5 SS XELJANZ TOFACITINIB CITRATE 1 Oral 5 MG, 2X/DAY 270 MG 203214 5 MG TABLET BID
1236767215 12367672 6 SS PREDNISONE. PREDNISONE 1 10 MG, DAILY Y 0 10 MG
1236767215 12367672 7 SS PREDNISONE. PREDNISONE 1 5 MG, 1X/DAY Y 0 5 MG QD
1236767215 12367672 8 C GABAPENTIN. GABAPENTIN 1 Oral UNK 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
1236767215 12367672 1 Rheumatoid arthritis
1236767215 12367672 6 Peripheral swelling
1236767215 12367672 8 Rheumatoid arthritis

Outcome of event

Event ID CASEID OUTC COD
1236767215 12367672 OT
1236767215 12367672 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
1236767215 12367672 Abdominal pain upper
1236767215 12367672 Activities of daily living impaired
1236767215 12367672 Anxiety
1236767215 12367672 Arthralgia
1236767215 12367672 Asthenia
1236767215 12367672 Back pain
1236767215 12367672 Bone neoplasm
1236767215 12367672 Bowel movement irregularity
1236767215 12367672 Choking
1236767215 12367672 Contusion
1236767215 12367672 Cough
1236767215 12367672 Cyst
1236767215 12367672 Depression
1236767215 12367672 Diarrhoea
1236767215 12367672 Diverticulitis
1236767215 12367672 Drug ineffective
1236767215 12367672 Fall
1236767215 12367672 Fatigue
1236767215 12367672 Joint swelling
1236767215 12367672 Limb mass
1236767215 12367672 Malaise
1236767215 12367672 Migraine
1236767215 12367672 Nasal congestion
1236767215 12367672 Nasopharyngitis
1236767215 12367672 Oropharyngeal pain
1236767215 12367672 Pain
1236767215 12367672 Pain in extremity
1236767215 12367672 Peripheral swelling
1236767215 12367672 Pollakiuria
1236767215 12367672 Rectal haemorrhage
1236767215 12367672 Sensitivity to weather change
1236767215 12367672 Stress
1236767215 12367672 Walking aid user

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
1236767215 12367672 1 20160216 201603 0
1236767215 12367672 2 20160302 20160328 0
1236767215 12367672 3 20160410 0
1236767215 12367672 4 20160418 20160711 0
1236767215 12367672 5 20160721 0
1236767215 12367672 6 201602 201602 0
1236767215 12367672 7 20160302 201603 0